# A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

> **NCT01042652** · NA · UNKNOWN · sponsor: **Centers for Disease Control and Prevention, China** · enrollment: 60 (estimated)

## Conditions studied

- HIV
- HIV Infections

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT01042652
- **Lead sponsor:** Centers for Disease Control and Prevention, China
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01042652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01042652, "A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01042652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*